Status:
COMPLETED
Sustaining Aviator Performance During Extended Operational Flight
Lead Sponsor:
United States Army Aeromedical Research Laboratory
Conditions:
Transcranial Direct Current Stimulation
Eligibility:
MALE
18-40 years
Phase:
NA
Brief Summary
Future aviation operations are anticipated to change as advances in technology enable automation of more tasks. Development of new platforms under the Future Vertical Lift program are also anticipated...
Detailed Description
Volunteers will first schedule an appointment to complete informed consent, screening procedures and meet with study physician. After eligibility is verified, volunteers will complete baseline assessm...
Eligibility Criteria
Inclusion
- Must be a male 18 (Active Duty) or 19 (National Guard, Reservist) to 40 years old.
- Must be a rated rotary-wing aviator with at least 200 hours of total flight experience, and have flown (aircraft or simulator) within the past 6 months, assessed by self-report.
- Must have a current DD-2292 (up-slip indicating clear for flight duties). Subjects will self-report this on the medical history questionnaire (Appendix A).
- Must have obtained at minimum 6 hours of sleep prior to data collection, as assessed by actigraphy data and self-report.
- Must have refrained from consumption of caffeine and medications that cause drowsiness, 16 hours, nicotine, 2 hours, and alcohol, 24 hours, prior to the study, assessed by self-report.
Exclusion
- Not having a current DD-2992.
- The following medically-related exclusionary criteria will be used, as assessed and verified by the study physician (in addition to possessing a DD-2992):
- Currently taking medications which induce drowsiness, such as over-the-counter antihistamines. Any self-medication will be assessed through self-report
- No current medical conditions or medications affecting cognitive function or attention.
- Any history of any attention deficit condition requiring medication.
- Any history of psychological/psychiatric disorder.
- Any history of seizures, migraines, or neurological disorders.
- History of a head injury involving loss of consciousness.
- Any metal implanted within the head (e.g., shrapnel, surgical clips) or any implanted devices (e.g., cardiac pacemaker, brain stimulator, hydrocephalic shunt).
- Skin condition on the scalp, such as psoriasis or eczema, or wounds on the head.
- Currently receiving hormonal therapy treatments.
- Potential for caffeine withdrawal symptoms that will impede cognitive testing.
Key Trial Info
Start Date :
November 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04697901
Start Date
November 9 2020
End Date
September 30 2021
Last Update
January 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
U.S. Army Aeromedical Research Laboratory
Fort Rucker, Alabama, United States, 36362